CCL5 and Familial prostate cancer: Given CCL5 is highly expressed by TAMs rather than prostate cancer cells, the combinational therapeutic strategy of blocking TAMs and neutralizing CCL5 may be a promising and powerful approach for PCSCs elimination in the future.